HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clonal variation in the B-lineage acute lymphoblastic leukemia response to multiple cytokines and bone marrow stromal cells.

Abstract
The acquisition of genetic abnormalities in human B-lineage acute lymphoblastic leukemia (ALL) culminates in the clonal expansion of bone marrow (BM)-derived leukemic blasts. However, the response of leukemic cells to signals transduced by the BM microenvironment is not completely understood. The present study describes a new human B-lineage ALL cell line designated BLIN-4 (B LINeage-4). BLIN-4 cells respond to multiple cytokines/human BM stromal cell-derived molecules. One subline (BLIN-4E) undergoes cell death in the absence of BM stromal cells or cytokines and slowly proliferates on human BM stromal cells supplemented with interleukin (IL)-7 + FLT3-ligand. Another subline (BLIN-4L) slowly proliferates in the absence of cytokines and BM stromal cells and shows robust proliferation on BM stromal cells supplemented with IL-7 + FLT3-ligand. Although human BM stromal cells are comparable with IL-7 + FLT3-ligand in supporting proliferation of BLIN-4L cells, neutralizing antibody experiments demonstrate that BLIN-4L expansion on BM stromal cells is IL-7/FLT3-ligand independent. BLIN-4L could also respond to human thymic stromal lymphopoietin. BLIN-4E and BLIN-4L have the identical immunoglobulin heavy chain rearrangement and a CD10(+)/CD19(+)/CD20(-)/CD22(+)/CD40(+)/mu heavy chain(-) phenotype. The original BM leukemic blasts harbored a ring chromosome 4 with a low percentage of cells also having either trisomy 8 or trisomy 18. The BLIN-4 sublines maintained the ring chromosome 4, but the trisomy 8 and trisomy 18 segregated into BLIN-4E and BLIN-4L, respectively. Thus, the BLIN-4 sublines exhibit biological characteristics consistent with a potential evolution in B-lineage ALL involving subclones with decreasing requirements on the BM microenvironment.
AuthorsN Shah, L Oseth, H Tran, B Hirsch, T W LeBien
JournalCancer research (Cancer Res) Vol. 61 Issue 13 Pg. 5268-74 (Jul 01 2001) ISSN: 0008-5472 [Print] United States
PMID11431369 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Culture Media, Conditioned
  • Cytokines
  • Interleukin-7
  • Membrane Proteins
  • Proto-Oncogene Proteins
  • Receptors, Interleukin-7
  • flt3 ligand protein
  • FLT3 protein, human
  • Receptor Protein-Tyrosine Kinases
  • fms-Like Tyrosine Kinase 3
  • Thymic Stromal Lymphopoietin
Topics
  • Adolescent
  • Bone Marrow Cells (cytology, metabolism)
  • Burkitt Lymphoma (genetics, pathology)
  • Cell Division (drug effects)
  • Cell Lineage
  • Cell Survival (drug effects)
  • Clone Cells
  • Culture Media, Conditioned
  • Cytokines (pharmacology)
  • Female
  • Humans
  • Interleukin-7 (pharmacology)
  • Membrane Proteins (pharmacology)
  • Proto-Oncogene Proteins (biosynthesis)
  • Receptor Protein-Tyrosine Kinases (biosynthesis)
  • Receptors, Interleukin-7 (biosynthesis)
  • Stromal Cells (metabolism)
  • Tumor Cells, Cultured
  • fms-Like Tyrosine Kinase 3
  • Thymic Stromal Lymphopoietin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: